powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1023512100
Thaer Othman
Endocrinology
Los Angeles,
CA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (2)
CCN 050471
Hospital
CCN 555927
Nursing home
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
66
Unique beneficiaries
—
Total services
66
Distinct HCPCS
2
Medicare payment
$8K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 633 Endocrinology providers in CA — bottom quintile (cohort median 1,164).
PRESCRIBING · PART D · 2024
Total Rx claims
334
Beneficiaries
—
Total drug cost
$145K
Distinct drugs
14
Brand share
60.5%
Top prescribed drugs
Semaglutide
48 claims
Levothyroxine Sodium
39 claims
Dulaglutide
37 claims
Atorvastatin Calcium
25 claims
Empagliflozin
25 claims
QUALITY · MIPS · 2024
Final MIPS score
87.5
Quality
79.4
Cost
73.7
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.53%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.